We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+6.42%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.45B
AUM Growth
+$336M
Cap. Flow
+$603M
Cap. Flow %
41.48%
Top 10 Hldgs %
67.23%
Holding
768
New
375
Increased
70
Reduced
59
Closed
238

Sector Composition

Rank Sector Weight
1 Healthcare 11.15%
2 Financials 9.75%
3 Technology 2.87%
4 Industrials 2.67%
5 Consumer Discretionary 1.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHPM
326
DELISTED
CHP Merger Corp. Class A Common Stock
CHPM
$99K 0.01%
+10,000
New +$103K
CLAS
327
DELISTED
Class Acceleration Corp.
CLAS
$97K 0.01%
+10,000
New +$97.2K
ROOT icon
328
PUT
Root
ROOT
$799M
$96K 0.01%
+1,783
New +$539K
ESPR
329
PUT
DELISTED
Esperion Therapeutics
ESPR
$95K 0.01%
+22,500
New +$664K
WORK
330
CALL
DELISTED
Slack Technologies, Inc.
WORK
$93K 0.01%
93,900
+62,600
+200% +$2.62M
TLGA.WS
331
DELISTED
TLG Acquisition One Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
TLGA.WS
$90K 0.01%
+157,504
New +$99.2K
KEY icon
332
CALL
KeyCorp
KEY
$24.3B
$89K 0.01%
+17,800
New +$343K
NMMCW
333
DELISTED
North Mountain Merger Corp. Warrant
NMMCW
$88K 0.01%
80,257
+15,257
+23% +$24.1K
DGNR.WS
334
DELISTED
Dragoneer Growth Opportunities Corp. Redeemable warrants, each whole warrant exercisable for one Cla
DGNR.WS
$88K 0.01%
+55,280
New +$169K
CLAS.WS
335
DELISTED
Class Acceleration Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CLAS.WS
$88K 0.01%
+142,711
New +$123K
AJAX.WS
336
DELISTED
Capri Listco Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exer
AJAX.WS
$87K 0.01%
+51,362
New +$151K
SCPL
337
PUT
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$85K 0.01%
+100,000
New +$1.72M
TECH icon
338
PUT
Bio-Techne
TECH
$11.2B
$82K 0.01%
+40,000
New +$3.65M
CRHC.WS
339
DELISTED
Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CRHC.WS
$82K 0.01%
68,152
+33,152
+95% +$66.2K
FXI icon
340
CALL
iShares China Large-Cap ETF
FXI
$4.25B
$81K 0.01%
160,000
-158,400
-50% -$7.86M
REV
341
CALL
DELISTED
Revlon, Inc.
REV
$80K 0.01%
99,800
+28,800
+41% +$336K
ABUS icon
342
PUT
Arbutus Biopharma
ABUS
$923M
$79K 0.01%
+37,500
New +$145K
GLUU
343
CALL
DELISTED
Glu Mobile Inc.
GLUU
$79K 0.01%
+763,100
New +$8.5M
DKS icon
344
PUT
Dick's Sporting Goods
DKS
$18.4B
$77K 0.01%
+39,500
New +$2.84M
NBIX icon
345
PUT
Neurocrine Biosciences
NBIX
$16.5B
$77K 0.01%
6,500
-6,000
-48% -$629K
RIGL icon
346
PUT
Rigel Pharmaceuticals
RIGL
$785M
$77K 0.01%
10,690
+4,220
+65% +$167K
FE icon
347
FirstEnergy
FE
$27.1B
$75K 0.01%
+2,162
New +$70.6K
VNET
348
CALL
VNET Group
VNET
$2.14B
$75K 0.01%
+677,400
New +$24.9M
FSSIW
349
DELISTED
Fortistar Sustainable Solutions Corp. Warrant
FSSIW
$75K 0.01%
+106,746
New +$71.5K
AGIO icon
350
PUT
Agios Pharmaceuticals
AGIO
$1.95B
$74K 0.01%
24,400
+14,400
+144% +$713K

Similar funds

Cowen and Company's Q1 2021 Portfolio in Review

As of Q1 2021, Cowen and Company held 768 positions worth $1.45B, up 30% from $1.12B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Cowen and Company deployed $603M of net new capital in Q1 2021, opening 375 new positions and adding to 70 existing holdings. Its largest new stake was iTeos Therapeutics: 588,238 shares worth $20.1M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 4.9% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Freeport-McMoran, an estimated $5.42M trimmed.

  • Cowen and Company's largest Q1 2021 buy was iTeos Therapeutics: 588,238 shares worth $20.1M.
  • Cowen and Company added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2021, an estimated $151M increase.
  • Cowen and Company's biggest Q1 2021 reduction was Freeport-McMoran, cutting an estimated $5.42M.
  • Cowen and Company fully exited VanEck Semiconductor ETF in Q1 2021, selling an estimated $30.8M.
  • Cowen and Company's ten largest holdings make up 67% of its $1.45B portfolio in Q1 2021.
  • Cowen and Company opened 375 new positions and closed 238 in Q1 2021.
  • Cowen and Company's portfolio value rose 30% quarter-over-quarter to $1.45B.

Based on Cowen and Company's 13F filing for Q1 2021, filed 4 May 2021.